TY - JOUR
T1 - Use of Circulating Tumor DNA to Monitor Minimal Residual Disease Among Patients With Colorectal Cancer
AU - Chitwood, Holly
AU - Myers, Adria
PY - 2023/7/20
Y1 - 2023/7/20
N2 - The emergence of molecular analysis approaches that use circulating tumor DNA (ctDNA) to measure minimal residual disease is shifting the management of colorectal cancer and many solid tumor cancers. Analysis of ctDNA has sev.
AB - The emergence of molecular analysis approaches that use circulating tumor DNA (ctDNA) to measure minimal residual disease is shifting the management of colorectal cancer and many solid tumor cancers. Analysis of ctDNA has sev.
KW - circulating tumor DNA
KW - colorectal cancer
KW - ctDNA
KW - minimal residual disease
UR - http://www.scopus.com/inward/record.url?scp=85170199384&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85170199384&partnerID=8YFLogxK
U2 - 10.1188/23.CJON.369-374
DO - 10.1188/23.CJON.369-374
M3 - Article
C2 - 37677775
AN - SCOPUS:85170199384
SN - 1092-1095
VL - 27
SP - 369
EP - 374
JO - Clinical Journal of Oncology Nursing
JF - Clinical Journal of Oncology Nursing
IS - 4
ER -